News + Filings Transactions
|
Poukalov Konstantin
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/30/2023 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 20k | $4.11 | $82.2k | | 06/30/2023 |
| 06/23/2022 | LianBio | | Grant | Stock Option (Right to Buy) | 36.3k | $2.52 | $91.5k | | 06/23/2022 |
| 06/16/2022 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 7.2k | $5.09 | $36.9k | | 06/16/2022 |
| 05/26/2021 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 7.2k | $7.24 | $52.5k | | 05/26/2021 |
| 02/09/2021 | Landos Biopharma, Inc. | LABP | Purchase | Common Stock | 35k | $14.60 | $510.3k | By funds | 02/05/2021 |
| 02/09/2021 | Landos Biopharma, Inc. | LABP | Purchase | Common Stock | 64.7k | $13.80 | $893.3k | By funds | 02/05/2021 |
| 02/08/2021 | Landos Biopharma, Inc. | LABP | Purchase | Common Stock | 1.8k | $13.10 | $23.2k | By funds | 02/05/2021 |
| 02/08/2021 | Landos Biopharma, Inc. | LABP | Purchase | Common Stock | 86.7k | $12.53 | $1.1M | By funds | 02/05/2021 |
| 02/08/2021 | Landos Biopharma, Inc. | LABP | Purchase | Common Stock | 34.6k | $11.38 | $393.9k | By funds | 02/05/2021 |
| 02/08/2021 | Landos Biopharma, Inc. | LABP | Conversion | Series A Preferred Stock | 5.9M | $0.00 | $0 | By funds | 02/08/2021 |
| 02/08/2021 | Landos Biopharma, Inc. | LABP | Conversion | Series B Preferred Stock | 7.5M | $0.00 | $0 | By funds | 02/08/2021 |
| 02/08/2021 | Landos Biopharma, Inc. | LABP | Purchase | Common Stock | 1.2M | $16.00 | $20M | By funds | 02/08/2021 |
| 02/08/2021 | Landos Biopharma, Inc. | LABP | Conversion | Common Stock | 13.4M | $0.00 | $0 | By funds | 02/08/2021 |
| 02/05/2021 | Landos Biopharma, Inc. | LABP | Purchase | Common Stock | 27.5k | $11.14 | $305.8k | By funds | 02/05/2021 |
| 04/30/2020 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 14.5k | $16.00 | $232k | | 04/30/2020 |
| 12/08/2017 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Appreciation Right | 205k | $3.64 | $746.2k | | 12/08/2017 |
| 12/15/2016 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 350k | $4.66 | $1.6M | | 12/15/2016 |
| 11/11/2016 | Kadmon Holdings, Inc. | KDMN | Purchase | Common stock, par value $0.001 | 1000 | $5.96 | $6k | | 11/11/2016 |
| 11/11/2016 | Kadmon Holdings, Inc. | KDMN | Purchase | Common stock, par value $0.001 | 1000 | $5.91 | $5.9k | | 11/11/2016 |
| 11/11/2016 | Kadmon Holdings, Inc. | KDMN | Purchase | Common stock, par value $0.001 | 1000 | $5.95 | $6k | | 11/11/2016 |
| 11/11/2016 | Kadmon Holdings, Inc. | KDMN | Purchase | Common stock, par value $0.001 | 1000 | $5.43 | $5.4k | | 11/11/2016 |
|